What is the recommended approach to asymptomatic patients who develop a reactive PPD?

Journal of Family Practice

Volumn 55, Issue 2, 2006, Pages 163-165

  Sharma, Umang ^a   Morris, Carl ^a   Safranek, Sarah ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; PLACEBO; PYRAZINAMIDE; RIFAMPICIN; TUBERCULIN;

CHEMOPROPHYLAXIS; CLINICAL TRIAL; DRUG EFFICACY; EVIDENCE BASED MEDICINE; HUMAN; LIVER TOXICITY; META ANALYSIS; MONOTHERAPY; REVIEW; SPUTUM CULTURE; THORAX RADIOGRAPHY; TREATMENT DURATION; TUBERCULIN TEST; TUBERCULOSIS; UNSPECIFIED SIDE EFFECT;

ANTITUBERCULAR AGENTS; DIAGNOSIS, DIFFERENTIAL; HUMANS; PRACTICE GUIDELINES; SEVERITY OF ILLNESS INDEX; TUBERCULIN TEST; TUBERCULOSIS;

EID: 32844460508     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (10)

1. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 2000; 161:1376-1395.
2. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000; 161:S221-S247.
3. Jasmer RM, Nahid P, Hopewell PC. Clinical practice. Latent tuberculosis infection. N Engl J Med 2002; 347:1860-1866.
4. Ferebee SH. Controlled chemoprophylaxis trials in tuberculosis. A general review. Bibl Tuberc 1970; 26:28-106.
5. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. Bull World Health Organ 1982; 60:555-564.
6. Comstock GW. How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults? Int J Tuberc Lung Dis 1999; 3:847-850.
7. Ena J, Valls V. Short-course therapy with rifampin plus isoniazid, compared with standard therapy with isoniazid, for latent tuberculosis infection: a meta-analysis. Clin Infect Dis 2005; 40:670-676.
8. Jasmer RM, Saukkonen JJ, Blumberg HM, et al. Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a multicenter clinical trial. Ann Intern Med 2002; 137:640-647.
9. Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British Medical Research Council. A double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong. Am Rev Respir Dis 1992; 145:36-41.
10. Taylor, Z, Nolan CM, Blumberg HM. Controlling tuberculosis in the United States. MMWR Recomm Rep 2005; 54(RR-12):1-81.